Ignatowicz A, Kornafel J. Epidemiologia nowotworów złośliwych wczoraj i dziś. Fam Med Prim Care Rev 2008; 10(3): 848––852.
Karwasik-Kajszczarek K, Futyma K, Kubiatowski T, i wsp. Maspina: nowy cel terapii przeciwnowotworowej. Nowotwory 2010; 60(1): 50–54.
Navarro Rde L, Martins MT, de Araújo VC. Maspin expression in normal and neoplastic salivary gland. J Oral Pathol Med 2004;33(7): 435–440.
Schwarz S, Ettl T, Kleinsasser N, et al. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors. Oral Oncol 2008; 44(6): 563–570.
Ghazy SE , Helmy IM, Baghdadi HM. Maspin and MCM2 immunoprofiling in salivary gland carcinomas. Diagn Pathol 2011;26(6): 89.
Nakashima D, Uzawa K, Kasamatsu A, et al. Protein expression profiling identifies maspin and stathmin as potential biomarkers of adenoid cystic carcinoma of the salivary glands. Int J Cancer 2006; 118(3): 704–713